Filing Flows

Filing Flows › Abbott Laboratories (ABT) › Recalls, complaints & regulation

Abbott Laboratories (ABT): recalls, EPA violations, clinical trials and Federal Register

Abbott Laboratories (ABT) beyond its filings: 14 recalls in the last 12 months (203 in five years, 63 Class I); 2 EPA-regulated facilities in violation, $103K in penalties over five years; 3 Federal Register documents in a year; 83 active clinical trials.

Latest recalls

EPA facilities in violation

Facility (as registered)CityStatusPenalties
ABBOTT NUTRITIONSturgis, MIViolation Identified—

Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.

Abbott Laboratories' latest quarter

Abbott Laboratories, Q3 2026: revenue $13.0B (+14% year over year), operating margin 10.4%, net earnings $920M, operating cash flow $1.7B. The chart follows the revenue to costs, profit and cash.

Questions

Has Abbott Laboratories had any recalls?

203 recalls on file over five years from the FDA, CPSC and NHTSA; 14 in the last 12 months.

Has Abbott Laboratories been fined by the EPA?

The 104 EPA-regulated facilities on file under its name drew $103K in penalties over five years; 2 are in violation now.

How many clinical trials does Abbott Laboratories have?

83 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.